[1] | W.Y. Lau, Management of hepatocellular carcinoma. J R Coll Surg Edinb 47 (2002) 389-99. |
[2] | A.S. Befeler, and A.M. Di Bisceglie, Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 122 (2002) 1609-19. |
[3] | P.J. Johnson, The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis 5 (2001) 145-59. |
[4] | W.J. Chen, and C.P. Weisel, Concentration Changes of Halogenated disinfection by-Products in a Drinking Water Distribution System. J. Am. Water Works Assoc 90 (1998) 151-163. |
[5] | Iarc, International Agency for Research on Cancer,Trichloroethylene, Iarc Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Human. IARC, Lyon, France (1995) 75-158. |
[6] | H.J. Clewell, and M.E. Andersen, Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene. Crit Rev Toxicol 34 (2004) 385-445. |
[7] | J.L. Larson, and R.J. Bull, Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. Toxicol Appl Pharmacol 115 (1992) 268-77. |
[8] | L. Tao, S. Yang, M. Xie, P.M. Kramer, and M.A. Pereira, Effect of trichloroethylene and its metabolites, dichloroacetic acid and trichloroacetic acid, on the methylation and expression of c-Jun and c-Myc protooncogenes in mouse liver: prevention by methionine. Toxicol Sci 54 (2000) 399-407. |
[9] | S.R. Channel, J.R. Latendresse, J.K. Kidney, J.H. Grabau, J.W. Lane, L. Steel-Goodwin, and M.C. Gothaus, A subchronic exposure to trichloroethylene causes lipid peroxidation and hepatocellular proliferation in male B6C3F1 mouse liver. Toxicol Sci 43 (1998) 145-54. |
[10] | C. Dees, and C. Travis, Trichloroacetate stimulation of liver DNA synthesis in male and female mice. Toxicol Lett 70 (1994) 343-55. |
[11] | J.A. Styles, I. Wyatt, and C. Coutts, Trichloroacetic acid: studies on uptake and effects on hepatic DNA and liver growth in mouse. Carcinogenesis 12 (1991) 1715-9. |
[12] | S. Rietman, and S. Frankle, A Colorimetric Method for Determination of Serum Glutamic Oxaloacetic and Glutamic Pyruvic Transaminases. Am. J. Clin. Path 28 (1957). |
[13] | N. Gond, and S. Khadabadi, Hepatoprotective activity of Ficus carica leaf extract on rifampicin-induced hepatic damage in rats. Indian J Pharm Sci 70 (2008) 364-6. |
[14] | A. Belfield, and D.M. Goldberg, Revised assay for serum phenyl phosphatase activity using 4-amino-antipyrine. Enzyme 12 (1971) 561-73. |
[15] | L. Jendrassik, and P. Grof, Biochem. J 297 (1938) 81. |
[16] | P.J. Bosma, J.R. Chowdhury, C. Bakker, S. Gantla, A. de Boer, B.A. Oostra, D. Lindhout, G.N. Tytgat, P.L. Jansen, R.P. Oude Elferink, and et al., The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 333 (1995) 1171-5. |
[17] | E.W. Gold, A simple spectrophotometric method for estimating glycosaminoglycan concentrations. Anal Biochem 99 (1979) 183-8. |
[18] | N.J. Jacobs, and P.J. Vandemark, The purification and properties of the alpha-glycerophosphate-oxidizing enzyme of Streptococcus faecalis 10C1. Arch Biochem Biophys 88 (1960) 250-5. |
[19] | P. Trinder, Enzymatic Calorimetric Test Clin. Biochem. J 6 (1969) 24-27. |
[20] | N.W. Tietz, Textbook of Clinical Chemistry. W.B. Saunders CO Philadelphia (1999). |
[21] | D.S. Young, Effect of Drugs on Clinical Lab Test. 5th Ed. AACC press (2000). |
[22] | G.I. Abelev, Alpha-fetoprotein as a marker of embryo-specific differentiations in normal and tumor tissues. Transplant Rev 20 (1974) 3-37. |
[23] | D.W. Chan, and Y.C. Miao, Affinity chromatographic separation of alpha-fetoprotein variants: development of a mini-column procedure, and application to cancer patients. Clin Chem 32 (1986) 2143-6. |
[24] | M. Uotila, E. Ruoslahti, and E. Engvall, Two-site sandwich enzyme immunoassay with monoclonal antibodies to human alpha-fetoprotein. J Immunol Methods 42 (1981) 11-5. |
[25] | Y. Kuang, N. Salem, F. Wang, S.J. Schomisch, V. Chandramouli, and Z. Lee, A colorimetric assay method to measure acetyl-CoA synthetase activity: application to woodchuck model of hepatitis virus-induced hepatocellular carcinoma. J Biochem Biophys Methods 70 (2007) 649-55. |
[26] | D.F. Yao, Z.Z. Dong, and M. Yao, Specific molecular markers in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 6 (2007) 241-7. |
[27] | M.C. Kew, Serum aminotransferase concentration as evidence of hepatocellular damage. Lancet 355 (2000) 591-2. |
[28] | D.V. Gopal, and H.R. Rosen, Abnormal findings on liver function tests. Interpreting results to narrow the diagnosis and establish a prognosis. Postgrad Med 107 (2000) 100-2, 105-9, 113-4. |
[29] | W. Yeo, F.K. Mo, J. Koh, A.T. Chan, T. Leung, P. Hui, L. Chan, A. Tang, J.J. Lee, T.S. Mok, P.B. Lai, P.J. Johnson, and B. Zee, Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Ann Oncol 17 (2006) 1083-9. |
[30] | G. Zhang, Y. Miura, and K. Yagasaki, Effects of dietary powdered green tea and theanine on tumor growth and endogenous hyperlipidemia in hepatoma-bearing rats. Biosci Biotechnol Biochem 66 (2002) 711-6. |
[31] | G. Muralikrishnan, V. Amalan Stanley, and K. Sadasivan Pillai, Dual role of vitamin C on lipid profile and combined application of cyclophosphamide, methotrexate and 5-fluorouracil treatment in fibrosarcoma-bearing rats. Cancer Lett 169 (2001) 115-20. |
[32] | R.W. Clark, and R.C. Crain, Characterization of Alterations in Plasma Lipoprotein Lipid and Apoprotein Profiles Accompanying Hepatoma-Induced Hyperlipidemia in Rats. Cancer Res 46 (1986) 1894-1903. |
[33] | N.M. Abdel-Hamid, Premalignant variations in extracellular matrix composition in chemically induced hepatocellular carcinoma in rats. J Membr Biol 230 (2009) 155-62. |
[34] | G.W. Yip, M. Smollich, and M. Gotte, Therapeutic value of glycosaminoglycans in cancer. Mol Cancer Ther 5 (2006) 2139-48. |
[35] | S.S. Skandalis, M. Stylianou, D.H. Vynios, N. Papageorgakopoulou, and D.A. Theocharis, The structural and compositional changes of glycosaminoglycans are closely associated with tissue type in human laryngeal cancer. Biochimie 89 (2007) 1573-80. |
[36] | M.E. Tsara, A.D. Theocharis, and D.A. Theocharis, Compositional and structural alterations of proteoglycans in human rectum carcinoma with special reference to versican and decorin. Anticancer Res 22 (2002) 2893-8. |
[37] | A.D. Theocharis, Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin. Biochim Biophys Acta 1588 (2002) 165-72. |
[38] | A.D. Theocharis, D.H. Vynios, N. Papageorgakopoulou, S.S. Skandalis, and D.A. Theocharis, Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma. Int J Biochem Cell Biol 35 (2003) 376-90. |
[39] | S.S. Skandalis, D. Kletsas, D. Kyriakopoulou, M. Stavropoulos, and D.A. Theocharis, The greatly increased amounts of accumulated versican and decorin with specific post-translational modifications may be closely associated with the malignant phenotype of pancreatic cancer. Biochim Biophys Acta 1760 (2006) 1217-25. |
[40] | L.X. Qin, and Z.Y. Tang, Metastasis and Recurrence after Surgical Resection of Hepatocellular Recent Progress in Clinical and Related Basic Aspects Carcinoma. Current Cancer Therapy Reviews 1 (2005) 71-80. |
[41] | L.P. Borges, V.C. Borges, A.V. Moro, C.W. Nogueira, J.B. Rocha, and G. Zeni, Protective effect of diphenyl diselenide on acute liver damage induced by 2-nitropropane in rats. Toxicology 210 (2005) 1-8. |
[42] | Y. Wang, F.P. Kuhajda, J.N. Li, E.S. Pizer, W.F. Han, L.J. Sokoll, and D.W. Chan, Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients. Cancer Lett 167 (2001) 99-104. |
[43] | N. Yahagi, H. Shimano, K. Hasegawa, K. Ohashi, T. Matsuzaka, Y. Najima, M. Sekiya, S. Tomita, H. Okazaki, Y. Tamura, Y. Iizuka, K. Ohashi, R. Nagai, S. Ishibashi, T. Kadowaki, M. Makuuchi, S. Ohnishi, J. Osuga, and N. Yamada, Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. Eur J Cancer 41 (2005) 1316-22. |
[44] | C. Peraino, E.F. Staffeldt, and V.A. Ludeman, Early appearance of histochemically altered hepatocyte foci and liver tumors in female rats treated with carcinogens one day after birth. Carcinogenesis 2 (1981) 463-5. |